Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ACAD Stock Annual Income Statement. Download in Excel

ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

17.60
 
USD
  
0.44
  
(2.56%)
Previous close: 17.16  Open: 17.2  Bid: 16.5  Ask: 17.75
52 week range    
13.40   
   20.68
Mkt Cap: 2,879 M  Avg Vol (90 Days): 1,789,405
Last updated: Friday 16th May 2025

Stock Rankings

67
MarketXLS Rank
80
Value
63
Technical
60
Quality
How are these ranks calculated?
Search for a stock

Financials

ACAD Income Statement

Annual
Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
Amortization of intangibles-985000.0-1 M-1 M1 M1 M1 M4 M15 M
Basic EPS from continuing operations-1.6-1.79-1.05-1.34-0.371.37
Basic EPS total-1.6-1.79-1.05-1.34-0.371.37
Basic weighted shares outstanding101 M116 M123 M127 M147 M157 M160 M161683.0163819.0166 M
Cost of sales3 M-3 M-9 M-12 M11 M21 M19 M10 M42 M82 M
Depreciation-647000.0-843000.0-1 M-1 M1 M2 M2 M2 M2 M900000.0
DepreciationAndAmortization-647000.0-843000.0-1 M-1 M1 M2 M2 M2 M2 M900000.0
Diluted EPS total-1.63-2.34-2.36-1.94-1.6-1.79-1.05-1.34-0.371.36
Diluted normalized net income/share-1.34-0.371.36
Diluted weighted shares outstanding101 M116 M123 M126 M147 M157 M160 M161683.0163819.0166 M
Earnings from equity interest-281 M-168 M-213 M-51 M258 M
EarningsFromEquityInterestNetOfTax-281 M-168 M-213 M-51 M258 M
GainOnSaleOfPPE200000.03 M100000.0147 M
GainOnSaleOfSecurity-2 M997000.0-997000.02 M4 M5 M
GeneralAndAdministrativeExpense-3 M-3 M-4 M-4 M326 M389 M396 M369 M407 M488 M
Gross operating profit-2 M13 M-13 M205 M328 M421 M465 M507 M685 M876 M
Income before tax-164 M-270 M-288 M-244 M-234 M-281 M-168 M-213 M-51 M258 M
Income taxes330000.01 M1 M1 M876000.0611000.0351000.03 M10 M32 M
Interest income499000.03 M4 M5 M11 M7 M591000.07 M17 M25 M
MiscOtherSpecialCharges125 M-2 M997000.0-997000.02 M4 M5 M148 M
Net income from total operations-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M-61 M226 M
NetIncomeCommonStockholders-164 M-271 M-289 M-245 M-219 M-282 M-168 M-216 M-61 M226 M
NetIncomeContinuousOperations-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M-61 M226 M
NetIncomeDiscontinuousOperations72000.0200000.0400000.02 M
NetNonOperatingInterestIncomeExpense499000.03 M4 M5 M11 M7 M591000.07 M17 M25 M
Normalized income109 M
Operating income-165 M-273 M-417 M-247 M-247 M-287 M-170 M-224 M-73 M231 M
Operating income before depreciation (EBITDA)-166 M-268 M-286 M-242 M-235 M-284 M-167 M-211 M-45 M274 M
OperatingExpense162 M286 M404 M453 M566 M708 M635 M731 M758 M792 M
Other income net-125 M2 M-997000.0997000.0-2 M4 M-5 M-148 M
OtherGandA-3 M-3 M-4 M-4 M326 M389 M396 M369 M407 M488 M
OtherOperatingExpenses-2 M-363000.0-361000.0-5 M-2 M-3 M-4 M-5 M-5 M-6 M
OtherWriteOff-100000.0
PromotionAndAdvertising-2 M-16 M-40 M38 M51 M2 M6 M9 M21 M
ProvisionForGainLossOnDisposal72000.0200000.0400000.02 M
RentAndLandingFees-3 M-3 M-4 M-4 M
Research & development expense74 M99 M149 M187 M240 M319 M239 M362 M352 M303 M
ResearchExpense74 M99 M149 M187 M240 M319 M239 M362 M352 M303 M
Revenue per share-985000.0-1 M-1 M1 M1 M1 M4 M15 M
SalariesAndWages-40 M-55 M-76 M-82 M600000.068 M66 M67 M
Selling Gen & administrative expense88 M186 M255 M266 M326 M389 M396 M369 M407 M488 M
SellingAndMarketingExpense88 M186 M255 M266 M38 M51 M2 M6 M9 M21 M
SellingExpense88 M186 M255 M266 M
Total Income available for interest expense (EBIT)-164 M-270 M-288 M-244 M-234 M-287 M-170 M-213 M-51 M258 M
Total common shares outstanding113 M121 M125 M144 M155 M160 M161 M162 M165 M167 M
Total net income-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M-61 M226 M
Total ordinary shares167 M167 M167 M167 M167 M167 M167 M167 M167 M167 M
Total revenues61000.017 M125 M224 M339 M442 M484 M517 M726 M958 M
TotalExpenses165 M283 M395 M441 M577 M718 M646 M741 M800 M874 M
TotalRevenue61000.017 M125 M224 M339 M442 M484 M517 M726 M958 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader